广告
加载中

SHEIN获赴港上市备案通知书:或成首家以秘交形式完成IPO的互联网平台型企业

Stone Jin 2026-07-15 11:50
Stone Jin 2026/07/15 11:50

邦小白快读

EN
全文速览

本文核心信息是快时尚品牌SHEIN的赴港上市最新进展,相关干货整理如下

1. SHEIN已经获得中国证监会出具的境外发行上市备案通知书,此前SHEIN曾筹备赴美IPO、考虑伦交所挂牌,均因各类原因搁置,目前已向港交所秘交上市申请,获得聆讯前置条件。

2. 本次SHEIN或将成为首家以秘交形式完成IPO的互联网平台型企业,由于SHEIN不属于允许秘交申请的特专科技或生物科技公司,将以个别获豁免者的身份完成秘交挂牌。

3. 资本层面,SHEIN过往最高估值达1000亿美元,本次港股IPO预计市值在400至500亿美元之间,背后投资方包括红杉中国、顺为资本、IDG资本等多家知名投资机构。当前港交所拟将秘交申请范围扩容至所有新申请人,但尚未正式生效。

本文披露了头部出海品牌SHEIN的最新资本动态,以及香港资本市场的规则变化,对品牌发展和融资有诸多参考价值,整理如下

1. 资本路径参考:SHEIN先后放弃美股、伦交所上市计划,最终转向港股IPO,反映出当前中资出海品牌对上市地点的选择新趋势,品牌规划自身融资路径时可参考这一方向调整布局。

2. 赛道资本认可度:SHEIN最高估值达到1000亿美元,本次IPO预计市值400-500亿美元,获得红杉中国、顺为资本等多家顶级投资机构加持,说明出海快时尚赛道依然获得资本高度认可,反映出海消费品牌具备较强发展潜力。

3. 融资环境变化:香港交易所持续优化上市机制,推出科企专线开放秘交申请,还拟将秘交范围扩容至所有新申请人,上市流程更灵活,能降低企业披露风险,有意赴港融资的品牌可关注规则落地进度,把握融资机会。

本文带来了头部出海企业SHEIN的上市最新动态,以及香港资本市场的规则变化,对有意融资或上市的出海卖家有诸多参考干货,整理如下

1. 政策变化参考:香港证监会和港交所2025年推出科企专线,允许特专科技、生物科技企业以保密形式提交上市申请,目前拟将秘交申请范围扩容到所有新申请人,规则优化后将降低企业上市过程中的信息披露风险,有意赴港上市的卖家可密切关注规则落地进度,提前做好准备。

2. 行业动向参考:头部出海品牌SHEIN放弃欧美市场交易所转向港股上市,反映出当前中资出海企业更偏好香港资本市场的新趋势,卖家可跟随这一资本流向变化,提前规划自身的融资与上市路径。

3. 风险提示:SHEIN的上市之路历经多次调整,受多重主观客观因素影响,卖家规划上市时要提前准备多套备选方案,应对外部环境变化带来的不确定性,降低上市进程受阻的风险。

本文披露了头部快时尚跨境品牌SHEIN的最新资本动态,对服务出海品牌的上游工厂有诸多参考价值,干货整理如下

1. 商业机会:SHEIN本身是年营收数百亿美元、净利润数十亿美元的头部快时尚龙头,本次成功拿到赴港上市备案,完成IPO后将获得更多发展资金,进一步扩大业务规模,对上游供应链工厂而言,将释放更多的订单需求,有意和SHEIN合作的工厂可提前对接布局,把握增长机会。

2. 发展转型启示:SHEIN的快速成长印证了快时尚出海赛道的增长潜力,也证明了小单快反柔性供应链模式的成功,上游生产工厂可借鉴这一思路,加快推进自身数字化升级,适配品牌端多批次小批量的快速生产需求,提升自身的市场竞争力。

3. 资本化参考:头部出海品牌纷纷转向港股上市,香港上市规则也在不断优化,有资本化规划的工厂也可关注相关规则变化,提前规划自身的上市路径。

本文披露了赴港上市相关的行业动向和规则变化,对为企业提供上市、跨境相关服务的服务商有诸多参考,干货整理如下

1. 行业发展趋势:香港交易所持续优化上市机制,从2018年的上市改革到2025年推出科企专线,再到拟将保密上市申请的适用范围扩容到所有新申请人,整体上市机制朝着更灵活、更适配企业需求的方向发展,未来会有更多中国企业选择赴港上市,服务商可重点布局拓展赴港上市相关的服务业务,抓住行业增长机会。

2. 客户痛点挖掘:企业上市过程中,过早披露营运策略、核心技术或上市计划,会带来较高的市场竞争风险,港交所推出的秘交上市制度刚好匹配企业降低披露风险的需求,服务商可针对这一需求,设计适配秘交规则的上市服务产品,满足客户需求。

3. 能力储备提示:目前已经有头部互联网平台型企业申请以个别豁免方式获得秘交资格,说明市场对秘交上市有广泛需求,服务商可提前储备相关业务能力,应对未来规则扩容后的市场需求。

本文披露了港交所最新的上市制度改革动向,以及SHEIN赴港上市的案例,对各类平台商的运营发展有诸多参考,干货整理如下

1. 需求变化参考:越来越多的中国头部互联网企业放弃欧美交易所,转向香港交易所上市,反映出企业对更贴近本土、规则更灵活的平台的需求,平台商需要密切关注用户需求的变化,及时调整自身规则和服务,提升对用户的吸引力。

2. 运营管理参考:港交所的发展路径值得借鉴,港交所通过持续多次改革,推出科企专线、开放秘交申请、拟扩容秘交适用范围,不断优化上市流程,平衡投资者保护和企业需求,有效吸引了优质企业入驻,巩固了自身的市场地位,平台商可借鉴这种与时俱进调整规则适配用户需求的运营思路。

3. 风险规避提示:本次SHEIN以个别豁免方式实现秘交上市属于现有规则下的特例,平台调整规则时需要平衡企业需求和用户权益,逐步推进规则优化,规避规则落地带来的风险,同时可针对性调整招商策略,吸引优质头部企业入驻。

本文记录了中概股赴港上市的最新案例,以及香港上市制度改革的最新动向,对产业和资本市场研究有较高的价值,干货整理如下

1. 产业新动向:此前不少选择赴美上市的中国新经济企业,陆续转向港股上市,SHEIN放弃美股、伦交所上市计划最终赴港IPO就是典型案例,反映出当前中概股资本布局的新趋势,同时香港上市制度持续改革,逐步放开秘交申请范围,对不同类型企业的适配性不断提升,这一趋势值得持续跟踪研究。

2. 新问题呈现:现有规则下秘交上市仅覆盖特专科技和生物科技企业,成熟互联网平台型企业无法直接适用,本次SHEIN以个别豁免方式申请,反映出现有规则在适配多元化企业需求方面存在不足,为上市规则的完善提供了现实研究案例。

3. 政策研究启示:香港交易所通过持续改革上市机制,吸引优质企业入驻,巩固自身国际金融中心地位的路径,对资本市场改革研究提供了新的样本,也为研究新经济企业的资本路径选择、跨境上市规则调整提供了鲜活案例。

返回默认

声明:快读内容全程由AI生成,请注意甄别信息。如您发现问题,请发送邮件至 run@ebrun.com 。

我是 品牌商 卖家 工厂 服务商 平台商 研究者 帮我再读一遍。

Quick Summary

This article covers the latest progress of fast fashion giant SHEIN's Hong Kong IPO, with key takeaways below:

1. SHEIN has obtained the offshore listing filing approval from the China Securities Regulatory Commission. It previously aborted plans for U.S. and London IPOs for various reasons, and has now confidentially submitted its listing application to the Hong Kong Stock Exchange (HKEX), securing the precondition for a hearing.

2. SHEIN is set to become the first internet platform company to complete an IPO via confidential submission. Since it does not qualify as a specialized technology or biotech firm (the only categories currently eligible for confidential filing), it will proceed as an individually exempted case.

3. Previously, SHEIN reached a peak valuation of $100 billion, backed by prominent investors including Sequoia China, Sequoia Capital, Shunwei Capital and IDG Capital. Its Hong Kong IPO is expected to value the company between $40 billion and $50 billion. HKEX has proposed expanding the scope of confidential filing to all new applicants, though the rule change has not yet taken effect.

This article discloses the latest capital developments of leading cross-border brand SHEIN and rule changes in Hong Kong's capital market, offering valuable references for brand development and financing:

1. Reference for capital roadmapping: SHEIN abandoned its U.S. and London listing plans and ultimately turned to Hong Kong, reflecting a new trend in listing location selection for Chinese cross-border brands. Brands can adjust their own financing roadmaps with this shift in mind.

2. Capital recognition for the cross-border track: Backed by top-tier investors including Sequoia China and Shunwei Capital, SHEIN boasted a $100 billion peak valuation and is projected to command a $40–50 billion market cap at its Hong Kong IPO. This signals strong sustained capital confidence in the cross-border fast fashion track, and underscores the strong growth potential of Chinese cross-border consumer brands.

3. Shifting financing landscape: HKEX has been continuously optimizing its listing mechanisms, launching the specialist technology company route that allows confidential filing, and is preparing to expand eligibility for confidential filing to all new applicants. This makes the listing process more flexible and reduces corporate disclosure risks. Brands planning to list in Hong Kong should monitor the progress of rule implementation to capture financing opportunities.

This article shares the latest listing updates of leading cross-border enterprise SHEIN and rule changes in Hong Kong's capital market, with key takeaways for cross-border sellers pursuing financing or listing:

1. Reference for policy changes: In 2025, the Hong Kong Securities and Futures Commission and HKEX launched the specialist technology company route, allowing specialized technology and biotech firms to submit listing applications confidentially. HKEX now plans to expand this eligibility to all new applicants. The optimized rules will cut information disclosure risks during the listing process, and sellers planning a Hong Kong listing should closely follow rule implementation and prepare in advance.

2. Reference for industry trends: Leading Chinese cross-border brand SHEIN's shift from Western exchanges to Hong Kong reflects a growing preference among Chinese cross-border firms for Hong Kong's capital market. Sellers can adjust their financing and listing roadmaps in advance to align with this capital flow trend.

3. Risk reminder: SHEIN's listing journey has undergone multiple adjustments due to a range of internal and external factors. Sellers should prepare multiple alternative plans when mapping out their listing process to address uncertainty from changing external conditions and reduce the risk of delayed listing progress.

This article discloses the latest capital updates of leading cross-border fast fashion brand SHEIN, with key insights for upstream factories that serve cross-border brands:

1. New business opportunities: SHEIN is a leading fast fashion giant with annual revenue in the hundreds of billions of dollars and net profit in the tens of billions of dollars. Having secured its offshore listing filing approval, it will gain more growth capital after completing its IPO and further expand its business scale, which will translate into more order demand for upstream supply chain factories. Factories interested in partnering with SHEIN can prepare and build connections in advance to capture growth opportunities.

2. Inspiration for transformation: SHEIN's rapid growth confirms the growth potential of the cross-border fast fashion track and validates the success of the small-batch, fast-turnaround flexible supply chain model. Upstream manufacturing factories can learn from this model, accelerate their own digital upgrades, adapt to the multi-batch, small-volume fast production demand from brands, and improve their market competitiveness.

3. Reference for capitalization plans: More leading cross-border brands are choosing to list in Hong Kong, and Hong Kong's listing rules are continuously improving. Factories with capitalization plans can also follow relevant rule changes and map out their own listing paths in advance.

This article discloses industry trends and rule changes related to Hong Kong listings, offering key references for service providers supporting corporate listing and cross-border business:

1. Industry development trends: HKEX has been continuously optimizing its listing mechanisms: from the 2018 listing reform to the 2025 launch of the specialist technology company route, and now the proposed expansion of confidential listing eligibility to all new applicants. The overall listing framework is evolving to become more flexible and better aligned with corporate demand. More Chinese companies will choose to list in Hong Kong going forward, and service providers can prioritize expanding their Hong Kong listing service lines to capture industry growth opportunities.

2. Identifying unmet client needs: Premature disclosure of operating strategies, core technology or listing plans exposes companies to high competitive risk during the IPO process. HKEX's confidential filing regime directly addresses enterprises' demand for lower disclosure risk. Service providers can design custom listing service products adapted to confidential filing rules to meet this client demand.

3. Preparing for growing demand: A leading internet platform company has already secured confidential filing eligibility via individual exemption, demonstrating broad market demand for confidential listings. Service providers should build relevant operational capabilities in advance to prepare for market demand after the rule expansion takes effect.

This article discloses the latest listing reform developments at HKEX and the case study of SHEIN's Hong Kong IPO, offering key references for the operation and development of all types of platform businesses:

1. Reference for shifting demand: A growing number of leading Chinese internet companies are abandoning Western exchanges for HKEX, reflecting corporate demand for platforms that are closer to home and offer more flexible rules. Platform operators need to closely track changing user demand, adjust their rules and services in a timely manner, and improve their attractiveness to users.

2. Reference for operational management: HKEX's growth path offers a valuable reference. Through multiple consecutive reforms—launching the specialist technology route, opening up confidential filing, and proposing to expand the scope of confidential eligibility—it has continuously optimized its listing process, balanced investor protection with corporate demand, effectively attracted high-quality issuers, and consolidated its market position. Platform operators can learn from this approach of updating rules in line with user demand to stay competitive.

3. Risk mitigation guidance: SHEIN's confidential listing via individual exemption is a special case under current rules. When adjusting their own rules, platforms need to balance corporate demand and user interests, roll out rule optimizations gradually, mitigate risks associated with rule implementation, and adjust their recruitment strategies to attract high-quality leading players.

This article documents the latest case of U.S.-listed Chinese concept stocks relisting in Hong Kong and the newest developments in Hong Kong's listing reform, offering high value for industrial and capital market research:

1. New industrial trends: A growing number of Chinese new economy firms that previously planned for U.S. listings have shifted to Hong Kong, with SHEIN's abandonment of U.S. and London plans as a prominent example. This reflects a new trend in capital allocation for Chinese concept stocks. Meanwhile, continuous reform of Hong Kong's listing rules, which is gradually expanding the scope of confidential filing, has improved the regime's adaptability to different types of firms. This trend is worthy of continued research and tracking.

2. Emerging new research questions: Under current rules, confidential listing is only open to specialized technology and biotech firms, and cannot be directly applied to mature internet platform companies. SHEIN's application via individual exemption exposes the gap between existing rules and diversified corporate demand, providing a real-world case study for improving listing frameworks.

3. Insights for policy research: HKEX's path of attracting high-quality issuers through continuous listing reform and consolidating its status as an international financial center provides a new sample for capital market reform research. It also offers a fresh case study for research on capital path selection of new economy firms and cross-border listing rule adjustments.

Disclaimer: The "Quick Summary" content is entirely generated by AI. Please exercise discretion when interpreting the information. For issues or corrections, please email run@ebrun.com .

I am a Brand Seller Factory Service Provider Marketplace Seller Researcher Read it again.

或以“个别获豁免者”的身份完成秘交及挂牌。

据IPO早知道消息,中国证监会国际合作司于7月10日披露了《关于SHEIN Global Holdings Limited(希音国际控股有限公司)境外发行上市备案通知书》。

这意味着,SHEIN稍早前已向港交所秘交上市申请,并已获得聆讯的前置条件。当然,SHEIN的上市之路也并不一帆风顺——早在2020年年初,「IPO早知道」就独家报道其正筹备赴美IPO事宜,彼时仍是中国新经济企业赴美上市的“黄金时期”,只不过后因一些主观与客观的原因搁置了美股上市进程。而后,SHEIN亦曾考虑在伦交所挂牌上市,最终同样未果。

在过去数年内,SHEIN的估值曾一度高达1000亿美元,而本次港股IPO发行价市值或将介于400至500亿美元之间,其背后的投资方包括集富亚洲、IDG资本、景林投资、嘉远资本、红杉中国、顺为资本、老虎环球基金、博裕资本、泛大西洋投资、Coatue、穆巴达拉等。

更值得注意的是,SHEIN本次赴港上市获批,或将使其成为第一家以秘交形式完成IPO的互联网平台型企业。

2025年5月6日,香港证监会与香港交易所发出联合公告,宣布正式推出"科企专线",以进一步便利特专科技公司及生物科技公司申请上市,并允许这些公司可以选择以保密形式提交上市申请。

公告指出,特专科技公司及生物科技公司一般处于早期发展阶段或产品尚未商业化的阶段。与其他行业相比,过早或长期披露公司的营运策略、专有技术或上市计划,可能会为这些公司带来过高的风险。为帮助这些公司减轻有关风险,联交所将允许根据《主板上市规则》第十八C章及十八A章上市的公司以保密形式提交申请版本。

显然,年营收数百亿美元、净利润数十亿美元的SHEIN并不属于特专科技公司或生物科技公司。换言之,SHEIN或将以“个别获豁免者”的身份完成秘交及挂牌。

而另根据今年3月13日港交所刊发的咨询文件,拟将以保密形式提交上市申请的适用范围将扩大至所有新申请人,允许任何申请人选择在递交申请时不立即登载申请版本,同时优化退回机制。这一咨询期历时八周,至2026年5月8日结束。截至目前,尚未有任何正式文件披露本次“扩容”正式生效。

香港交易所上市主管伍洁镟彼时表示:“香港交易所致力确保我们的上市机制稳健且富有竞争力,巩固香港作为领先国际金融中心的地位。我们在与持份者深入沟通后发现,他们普遍希望把握更多优质的创新投资机遇,也希望上市机制在确保投资者信任和信心的同时可以更加高效和与时俱进。因此,我们提出了这些建议。”

“我们在2018年成功地进行了一系列上市改革,从根本上重塑了香港股票市场的结构,吸引了一大批创新公司来港上市,这次的建议正是基于这些改革成果而提出的。我们欢迎大家对这些建议发表意见,并期待继续与持份者保持沟通。让我们共同努力,巩固香港作为成长型企业首选集资地和全球资本布局亚洲首选市场的地位。”伍洁镟说到。

注:文/Stone Jin,文章来源:IPO早知道(公众号ID:ipozaozhidao),本文为作者独立观点,不代表亿邦动力立场。

文章来源:IPO早知道

广告
微信
朋友圈

FAQ回顾

SHEIN赴港上市的最新进展是什么?

2024年7月10日中国证监会已披露SHEIN境外发行上市备案通知书,其此前已向港交所秘交上市申请,获得聆讯前置条件,本次港股IPO预计市值介于400至500亿美元之间,或将成为首家以秘交形式完成IPO的互联网平台型企业。

香港秘交上市目前的适用范围有哪些?

2025年5月香港证监会与港交所推出“科企专线”,允许符合《主板上市规则》第十八C章、十八A章的特专科技、生物科技公司以保密形式提交上市申请;2025年3月港交所发布咨询文件拟扩大范围至所有新申请人,目前扩容尚未生效。

SHEIN为什么能适用秘交上市政策?

SHEIN年营收数百亿美元、净利润数十亿美元,不属于特专科技或生物科技公司,不满足常规秘交上市的适用要求,本次或将以“个别获豁免者”的身份完成秘交及挂牌流程。

这么好看,分享一下?

朋友圈 分享

APP内打开

+1
+1
微信好友 朋友圈 新浪微博 QQ空间
关闭
收藏成功
发送
/140 0